Dysbiosis of infant gut microbiota is related to the altered fatty acid composition of human milk from mothers with gestational diabetes mellitus: a prospective cohort study
Kelei Li,
No information about this author
Jin Jin,
No information about this author
Zhizuo Liu
No information about this author
et al.
Gut Microbes,
Journal Year:
2025,
Volume and Issue:
17(1)
Published: Jan. 21, 2025
Gestational
diabetes
mellitus
(GDM)
is
known
to
be
associated
with
dysbiosis
of
offspring
gut
microbiota,
but
the
mechanism
remains
unclear.
The
present
prospective
study
explored
role
human
milk
fatty
acid
composition
in
this
association.
Mothers
GDM
and
normal
controls
were
recruited
at
24–28
gestational
weeks.
Follow-up
was
conducted
1–3
days
postpartum
1
month
collect
infant
feces.
A
total
80
mother-infant
pairs
(40
group
40
group)
included
study.
mothers
received
guidance
on
diet
exercise
not
drug
therapy.
All
infants
exclusively
breastfed.
We
observed
significant
differences
8
phyla
13
genera
between
groups
or
postpartum.
Among
these
bacteria,
time
×
interaction
for
7
(such
as
Acidobacteriota,
Gemmatimonadota,
Myxococcota)
9
Sphingomonas,
Allorhizobium
Neorhizobium
Pararhizobium
Rhizobium,
TM7a),
after
adjusting
confounding
factors.
Changes
differential
bacteria
negatively
correlated
changes
C18:3n-3
n-3
PUFA
levels
breast
milk.
increases
over
much
greater
compared
group.
Our
findings
indicate
that
altered
one
important
reason
GDM-related
microbiota.
Language: Английский
In Silico Identification of Peanut Peptides Suitable for Allergy Immunotherapy in HLA-DRB1*03:01-Restricted Patients
Pharmaceuticals,
Journal Year:
2024,
Volume and Issue:
17(8), P. 1097 - 1097
Published: Aug. 21, 2024
Peanut
allergy,
a
prevalent
and
potentially
severe
condition
affecting
millions
worldwide,
has
been
linked
to
specific
human
leukocyte
antigens
(HLAs),
suggesting
increased
susceptibility.
Employing
an
immunoinformatic
strategy,
we
developed
“logo
model”
based
on
amino
acid
frequencies
in
the
peptide
binding
core
used
it
predict
peptides
originating
from
28
known
peanut
allergens
HLA-DRB1*03:01,
one
of
susceptibility
alleles.
These
hold
promise
for
immunotherapy
HLA-DRB1*03:01
carriers,
offering
reduced
allergenicity
compared
whole
proteins.
By
targeting
essential
epitopes,
can
modulate
immune
responses
with
minimal
risk
reactions.
This
precise
approach
could
induce
tolerance
fewer
adverse
effects,
presenting
safer
more
effective
treatment
allergy
other
allergic
conditions.
Language: Английский